Protagonist Therapeutics
Price & Volume
Stats
See moreOpen | $47.03 |
Previous Close | $46.76 |
Day Range | $44.82-$47.03 |
52W Range | $14.78-$48.89 |
Market Cap | $2.7B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $319.1M |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | $26.5M |
Diluted EPS | $2.72 |
News
See moreYahoo Finance • 7 months ago
Turnstone Biologics Appoints William Waddill to its Board of Directors
Yahoo Finance • 9 months ago
Steven Cohen Adjusts Position in Protagonist Therapeutics Inc
Yahoo Finance • 9 months ago
Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License and Collaboration Agreement for Rusfertide, a Late-Stage Rare Hematology Asset
Yahoo Finance • 10 months ago
A Look At The Fair Value Of Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
About
CEO | Dr. Dinesh V. Patel Ph.D. |
Address | 7707 Gateway Boulevard, Newark, CA, United States, 94560-1160 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 125 |
